Yuting Liu

4.2k total citations · 1 hit paper
83 papers, 3.0k citations indexed

About

Yuting Liu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yuting Liu has authored 83 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 19 papers in Oncology and 18 papers in Immunology. Recurrent topics in Yuting Liu's work include Cancer Immunotherapy and Biomarkers (8 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yuting Liu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yuting Liu collaborates with scholars based in China, United States and Greece. Yuting Liu's co-authors include Yi Zhang, Falong Lu, Shogo Matoba, David L. Rimm, Robert E. Dempski, Yan Xu, Kurt A. Schalper, Li Shen, Azusa Inoue and Kumiko A. Iwabuchi and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Yuting Liu

79 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Embryonic Development following Somatic Cell Nuclear Transfer Impeded by Persisting Histone Methylation

2014 356 citations Shogo Matoba, Yuting Liu et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuting Liu China	29	1.7k	698	629	435	307	83	3.0k
Arnaud Droit Canada	36	2.1k 1.2×	523 0.7×	468 0.7×	428 1.0×	255 0.8×	183	3.8k
Fatma Z. Guerfali Tunisia	9	2.1k 1.2×	377 0.5×	607 1.0×	785 1.8×	272 0.9×	27	3.8k
Tao Zhu China	26	1.0k 0.6×	410 0.6×	426 0.7×	282 0.6×	230 0.7×	74	2.1k
Davood Bashash Iran	31	1.6k 0.9×	659 0.9×	457 0.7×	537 1.2×	307 1.0×	200	3.6k
Alia Benkahla Tunisia	11	2.0k 1.2×	365 0.5×	541 0.9×	325 0.7×	201 0.7×	26	3.2k
Tingxiu Xiang China	36	2.5k 1.5×	632 0.9×	1.1k 1.7×	344 0.8×	341 1.1×	133	3.8k
Xiaowei Yan United States	31	1.3k 0.8×	563 0.8×	386 0.6×	822 1.9×	208 0.7×	119	3.5k
Yunping Zhu China	28	2.5k 1.5×	451 0.6×	464 0.7×	402 0.9×	250 0.8×	112	4.1k
Rong He United States	39	2.9k 1.7×	513 0.7×	388 0.6×	832 1.9×	254 0.8×	218	4.7k
Ashok Sharma United States	30	1.2k 0.7×	313 0.4×	399 0.6×	337 0.8×	211 0.7×	192	2.9k

Countries citing papers authored by Yuting Liu

Since Specialization

Citations

This map shows the geographic impact of Yuting Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuting Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuting Liu more than expected).

Fields of papers citing papers by Yuting Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuting Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuting Liu. The network helps show where Yuting Liu may publish in the future.

Co-authorship network of co-authors of Yuting Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuting Liu. A scholar is included among the top collaborators of Yuting Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuting Liu. Yuting Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fan, Xiaoxing, Xiaohan Li, Yuting Liu, et al.. (2025). Uncovering chromatin accessibility dynamics in early maize endosperm and seed coat differentiation. The Plant Journal. 123(2). e70316–e70316.

Ding, Fan, Yuting Liu, Jia Li, et al.. (2024). TC14012 enhances the anti-fibrosis effects of UC-MSCs on the liver by reducing collagen accumulation and ameliorating inflammation. Stem Cell Research & Therapy. 15(1). 44–44. 3 indexed citations

Li, Heming, Lu Xu, Tao Han, et al.. (2024). Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 129–129. 11 indexed citations

Che, Yan, Yuting Liu, Zhaopeng Wang, et al.. (2024). Cardiac tumour necrosis factor receptor-associated factor 7 mediates the ubiquitination of apoptosis signal-regulating kinase 1 and aggravates cardiac hypertrophy. Cardiovascular Research. 120(16). 2031–2046. 4 indexed citations

Liu, Yuting, Mengda Jiang, Tianyi Zhu, et al.. (2023). Immune-related visual dysfunction in thyroid eye disease: a combined orbital and brain neuroimaging study. European Radiology. 34(7). 4516–4526. 8 indexed citations

Liu, Yuting, Hao Zhang, Shao-Bin Duan, et al.. (2023). Mitofusin2 Ameliorated Endoplasmic Reticulum Stress and Mitochondrial Reactive Oxygen Species Through Maintaining Mitochondria-Associated Endoplasmic Reticulum Membrane Integrity in Cisplatin-Induced Acute Kidney Injury. Antioxidants and Redox Signaling. 40(1-3). 16–39. 12 indexed citations

Liu, Yuting, et al.. (2023). Alloprevotella Can be Considered as a Potential Oral Biomarker in Intestinal Metaphase of Gastric Patients. Studies in health technology and informatics. 308. 155–167. 11 indexed citations

Xiong, Ying, et al.. (2022). Trends in immune-related adverse events for colorectal cancer: A bibliometric analysis. Frontiers in Oncology. 12. 1024321–1024321. 1 indexed citations

Liu, Xu-Qing, Xinsheng Liu, Feng Gao, et al.. (2021). Precise diagnosis of three top cancers using dbGaP data. Scientific Reports. 11(1). 823–823. 2 indexed citations

10.

Ding, Hua, Yaqin Huang, Jiazhong Shi, et al.. (2021). Attenuated expression of SNF5 facilitates progression of bladder cancer via STAT3 activation. Cancer Cell International. 21(1). 655–655. 7 indexed citations

11.

Zugazagoitia, Jon, Swati Gupta, Yuting Liu, et al.. (2020). Biomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non–Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial Profiling. Clinical Cancer Research. 26(16). 4360–4368. 83 indexed citations

12.

Huang, Jihan, Feiyu Chen, Zhangfeng Zhong, et al.. (2020). Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental Evaluation. Frontiers in Pharmacology. 11. 414–414. 37 indexed citations

13.

Liu, Yuting, Jon Zugazagoitia, Fahad Shabbir Ahmed, et al.. (2019). Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy. Clinical Cancer Research. 26(4). 970–977. 225 indexed citations

14.

Liu, Yuting, Jingjing Wu, Kai Zhang, et al.. (2019). Application of metabolomics by UHPLC-MS/MS in diagnostics and biomarker discovery of non-small cell lung cancer. Translational Cancer Research. 8(6). 2371–2379. 1 indexed citations

15.

Sahraei, Mahnaz, Balkrishna Chaube, Yuting Liu, et al.. (2019). Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response. Journal of Clinical Investigation. 129(12). 5518–5536. 106 indexed citations

16.

Zugazagoitia, Jon, Yuting Liu, Maria Toki, et al.. (2019). Quantitative Assessment of CMTM6 in the Tumor Microenvironment and Association with Response to PD-1 Pathway Blockade in Advanced-Stage Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(12). 2084–2096. 49 indexed citations

17.

Bellone, Stefania, Natália Buza, Jungmin Choi, et al.. (2018). Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic Rearrangement. Clinical Cancer Research. 24(14). 3282–3291. 35 indexed citations

18.

Zhang, Yi, Shuyan Zhou, Shaoxiang Wang, et al.. (2015). Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway. Molecular Cancer. 14(1). 56–56. 86 indexed citations

19.

Matoba, Shogo, Yuting Liu, Falong Lu, et al.. (2014). Embryonic Development following Somatic Cell Nuclear Transfer Impeded by Persisting Histone Methylation. Cell. 159(4). 884–895. 356 indexed citations breakdown →

20.

田中, 義夫, Yuting Liu, Shinya Akatsuka, et al.. (2007). Association of microRNA‐34a overexpression with proliferation is cell type‐dependent. Cancer Science. 98(12). 1845–1852. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact